 |
 |

Evaluation of FlurandrenoloneA New Topical Corticosteroid
HOWARD R. GRAY, M.D.;
ROBERT L. WOLF, M.D.;
RONALD H. DONEFF, M.D.
Arch Dermatol. 1961;84(1):18-21.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
Flurandrenolone* is a new corticosteroid which has a chemical formula of 6 -fluoro-16 -hydroxyhydrocortisone-16,17-acetonide. This new steroid is distinguished from hydrocortisone by the presence of 2 activityenhancing groupings, a 6 -fluorine and a 16 -OH. The structural formula follows:
Substitution of an alpha-fluorine atom for hydrogen at the sixth position and a hydroxyl group at the 16 position, as well as the acetonide function linkage at both the 16 - and 17 -hydroxyl groups, are new substituents designed to impart maximum potency as an anti-inflammatory agent. At the same time, the salt-retaining property of the parent compound is decreased.1
Pharmacological animal data by Kraay confirmed this increased potency and decreased sodium retention.2 Flurandrenolone was assayed using the standard methods of thymus involution and inhibition of granuloma formation around a cellulose pellet in adrenalectomized rats. On the basis of thymus involution, flurandrenolone appeared to have about 10 times the oral potency of prednisolone and from
. . . [Full Text PDF of this Article]
Author Affiliations
INDIANAPOLIS
From the Department of Dermato-Syphilology, Marion County General Hospital (Chairman, Boynton H. Booth, M.D.).
Footnotes
Submitted for publication Feb. 27, 1961.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|